Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Agenus Inc AGEN

Healthcare Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AGEN)

Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting

Business Wire 2 days ago

Agenus to Provide First Quarter 2024 Financial Report and Corporate Update

Business Wire 3 days ago

Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer

Business Wire April 12, 2024

Agenus Announces Reverse Stock Split of Common Stock

Business Wire April 5, 2024

Agenus Reports Fourth Quarter and Full Year 2023 Results

Business Wire March 14, 2024

Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024

Business Wire March 6, 2024

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire March 5, 2024

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

Business Wire February 29, 2024

Agenus to Participate in Leerink Partners Global Biopharma Conference

Business Wire February 26, 2024
View More News ››

Opinion & Analysis (NDAQ:AGEN)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:AGEN)

No(w) Fun City?

Is there a short squeeze on?  No news, up 40% in a day. After the 20:1 consolidation, there were 21 million share outstanding an 2...
zalmonella - 3 hours ago

Top 2 Health Care Stocks Which Could Rescue Your Portfolio T

News; $AGEN Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month | BenzingaThe most oversold stocks in the health care...
whytestocks - 3 days ago

No fun city

Great.  One April 13 i will have 250 shares of this worthless stock for which I've paid over the years a total of $10,400.  ...
zalmonella - April 8, 2024

BUY BUY BUY BUY BUY

I will make this my third transaction tomorow
Nibinator - March 31, 2024

Reverse split

Now this morning a reverse split (8K) proposed at 1:20.
zalmonella - February 15, 2024

Agenus to Participate in Oppenheimer 34th Annual Healthcare

Breaking News: $AGEN Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceAgenus Inc. (&#x201C;Agenus...
whytestocks - January 31, 2024
View more Bullboard ››

Ucore Rare Metals Inc.

Ucore Rare Metals Inc.

Ucore is focused on rare and critical-metal resources, extraction, beneficiation, and separation technologies with the ...
View More »